Table 1.
Ref. | Incubation Period | Method for estimating the incubation period. | Number of cases | Location | Note |
---|---|---|---|---|---|
Incubation Period Studies | |||||
[1] | 6.4 days (95% CI: 5.6–7.7), ranging from 2.1 to 11.1 days (2.5th to 97.5th percentile) | Probability density function (PDF). Used a doubly interval-censored likelihood function to estimate the parameter values. Used RStan package in R | 88 | Outside Wuhan, China |
The study provides empirical evidence and the estimation is within the range for the incubation period of 0–14 days assumed by the WHO and of 2–12 days assumed by the ECDC [11]. |
[2] | 5 days (2–14 days with 95% confidence) | Best-fit lognormal distribution | Real-time data | outside of the Wuhan, China | Recommend the length of quarantine to be at least 14 days. The median time delay of 13 days from illness onset to death should be considered when estimating the fatality risk. |
[13] | SARS-CoV2 4.9 (95% CI:4.4.−5.5) SARS-CoV 4.7(95% CI: 4.3−5.1) MERS-CoV 5.8 (95% CI: 5−6.5) |
Fitted Weibull, lognormal, and gamma distributions | SARS-CoV2 49 SARS-CoV 153 MERS-CoV 70 |
China | long incubation time was reported to be associated with SARS‐CoV‐2 infection, leading to adjustments in screening and control policies. |
[14] | Median 5.1 days (95% CI, 4.5–5.8 days) | Estimated the incubation time using a previously described parametric accelerated failure time model. Doubly interval-censored data. Data reduction technique | 181 | Regions, and countries outside Wuhan, Hubei province, China | 101 out of every 10,000 cases (99th percentile, 482) develop symptoms after 14 days of active monitoring or quarantine. This work provides additional evidence for a median incubation period of approximately 5 days, like SARS. |
Transmission Characteristics | |||||
[15] | 5.2 days (95% confidence interval (CI): 4.1−7.0), with the 95th percentile of the distribution at 12.5 days | Estimated by fitting a log-normal distribution to data on exposure histories and onset dates in a subset of cases with detailed information available. | 10 | Wuhan, China | The estimation was based on information from only 10 cases and is somewhat imprecise. The incubation period reported is Within the WHO limit. |
[16] | Mean of 7.2 days | Gamma distribution and a log-normal distribution | – | Chinese provinces excluding Hubei | The authors stated that the recommended 14-day quarantine period may lead to a 6.7% failure for quarantine and they suggested a 22-day quarantine period. |
[17] | Mean incubation periods as 7.1 (6.13, 8.25) days for Singapore and 9 (7.92, 10.2) days for Tianjin |
Used interval censoring R package icenReg [18] to make parametric estimates of the incubation period distribution | 93 Singapore 135 Tianjin |
Singapore, Tianjin (China) | Both datasets had shorter incubation periods for earlier-occurring cases. |
[19] | Median incubation period was 6 (rang, 1−32) days, of 8 patients ranged from 18 to 32 days. |
Recorded Observation | 104 | Hunan, outside-Wuhan | The incubation period of 8 patients exceeded 14 days. |
[20] | 1−19 days | Observation | 5 | Anyang, China | The incubation period for patient 1 was 19 days, which is long but within the reported range of 0–24 days |
[21] | be 4.9 days (95% confidence interval [CI], 4.4–5.4) days, ranging from 0.8–11.1 days (2.5th to 97.5th percentile) | Used a Weibull distribution-based survival analysis model with the extension of the Kaplan-Meier estimator to fit the curve of the incubation period for COVID-19 cases. | 124 | Outside Wuhan city and Hubei province in China | 73.0% of the secondary cases, their date of getting infected was before symptom onset of the first-generation cases, particularly in the last 3 days of the incubation period. Strong and effective countermeasures should be implemented to prevent or mitigate asymptomatic transmission during the incubation period in populations at high risk. |
[22] | 5·2 days (1·8–12·4) and the mean serial interval at 5·1 days (1·3–11·6). | Lognormal distribution | 8579 cases from 30 provinces | outside Hubei in mainland China | The mean time from symptom onset to hospital admission decreased from 4·4 days (95% CI 0·0–14·0) from Dec 24 to Jan 27, to 2·6 days (0·0–9·0) for the period of Jan 28 to Feb 17. |
Clinical Characteristics | |||||
[23] | Median incubation period of 2.5 | Lognormal distribution | 34 | Wuhan | The length of time from hospital admission to surgery (median time, 2.5 days is shorter than the median incubation time of 5.2 days |
[24] | Median incubation period of 4 | Median, Observation (2−7 days) | 291 | Mainland China | The median age was 47 years, and 41.90% were females. Only 1.18% of patients had direct contact with wildlife, whereas 31.30% had been to Wuhan and 71.80% had contacted people from Wuhan. |
Case Study | |||||
[25] | Patient 3 – (3−6 days after exposure)Patients 1−4 symptomatic (6 −10 days after symptom onset) 5 not affected |
Observation | 5 | Wuhan | 5 patients (aged 36–66 years) The authors' findings are consistent with person-to-person transmission of the novel coronavirus in hospital and family settings, and the reports of infected travelers in other geographical regions. |
[26] | Mean of 8.09 (4.99) days | Mean, Observation | 44 | Xiangyang, China | Most cases fell into the age group of 50−70 years old. The rate of severe illness and death was low, whereas some patients had a longer incubation period. |
[27] | 2–14 days, and mostly 3–7 days. | Observation | 3 | Hunan, China | A 47-year-old woman with long-term use of glucocorticoids did not develop any symptoms within the 14- day quarantine period. The results suggest that the long-term use of glucocorticoids might cause atypical infections, a long incubation period, and extra transmission of COVID-19. Case 1 is a Wuhan-settled 47-year-old female. She has a more than 16-year history of systemic lupus erythematosus (SLE) Case 2 is an 81-year-old male who lives in Yiyang. He has a history of prostate cancer and coronary heart disease. Case 3 is a 44-year-old female from Yiyang. She also had close contact with her elder sister (Case 1). |
[28] | The Median incubation period is 4 days. | Observations | 36 | Tour group from China, in Singapore | Interpretation SARS-CoV-2 is transmissible in community settings, and local clusters of COVID-19 are expected in countries with high travel volume from China. Enhanced surveillance and contact tracing are essential to minimize the risk of widespread transmission in the community. |
Epidemiological Characteristics | |||||
[29] | Estimated average, mode and median incubation periods are 7.4, 4 and 7 days, respectively | log-normal distribution | 483 | Henan, China | COVID-19 patients show gender (55% vs 45%) and age (81% aged between 21 and 60) preferences, possible causes were explored. The incubation periods of 92% of the patients did not exceed 14 days. |